Group 1 - Thomas Rantzau, employee representative on the Board of Directors since 2018, has decided to leave Novo Nordisk A/S after 22 years of employment, stepping down from the Board [1] - Tanja Villumsen has been appointed as the new employee representative on the Board of Directors of Novo Nordisk A/S effective immediately [1] Group 2 - Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, focusing on defeating serious chronic diseases, particularly diabetes [2] - The company employs approximately 78,500 people across 80 countries and markets its products in around 170 countries [2] - Novo Nordisk's B shares are listed on Nasdaq Copenhagen, and its ADRs are listed on the New York Stock Exchange [2]

Core Insights - Hampton Financial Corporation reported solid performance in the first quarter of fiscal 2026, driven by its wealth management platform and alternative lending subsidiary, Oxygen Working Capital Corp. [1][3] - The company is focused on enhancing service offerings, improving operational efficiency, and driving long-term shareholder value through strategic opportunities. [2][10] Financial Performance - Q1 revenue was $2,397,000, a decrease of 23% compared to $3,133,000 in the same quarter last year [7] - The company reported a net loss of $(1,048,000), or $(0.02) per share, with an adjusted net loss of $(976,000), also $(0.02) per share [7] - Q1 EBITDA was $(221,000), down from $240,000 in the comparative quarter last year [7] Corporate Developments - Hampton completed the issuance of 10,528,141 subordinate voting shares to settle $4.0 million in debt obligations and approximately $5.2 million in quarterly interest payments, which is expected to strengthen the balance sheet and reduce operating costs [3][5] - The company continues to develop its wealth management, advisory, and capital markets services through its subsidiary, Hampton Securities Limited [4][6] - Oxygen, the commercial lending subsidiary, provides financing solutions to businesses across Canada, supporting their working capital needs [5][9]

Core Viewpoint - Bunker Hill Mining Corp. has successfully closed the seventh and final tranche of a silver loan, totaling approximately US$4.76 million, to support the restart and development of the Bunker Hill Mine [1][2]. Group 1: Silver Loan Details - The total principal amount of the silver loan is up to 1.2 million ounces of silver, advanced in multiple tranches [3]. - The first tranche was closed on August 8, 2024, for US$16,422,039, equivalent to 609,805 ounces of silver [3]. - Subsequent tranches included amounts of US$6,369,000 for 200,000 ounces, US$6,321,112 for 198,777 ounces, US$1,250,000 for 39,620 ounces, US$1,478,847 for 50,198 ounces, and US$2,521,215 for 50,384 ounces [3][4]. Group 2: Warrants Issued - A total of 3,000,000 non-transferable bonus share purchase warrants have been issued to Monetary Metals in connection with the silver loan, with no warrants issued for the final tranche [4]. Group 3: Company Overview - Bunker Hill Mining Corp. is focused on the restart of the historic Bunker Hill Mine, located in Idaho's Coeur d'Alene Mining District, known for its rich history in zinc, lead, and silver production [6]. - The company aims to unlock the remaining value of this asset through modern exploration and responsible mining practices, with a strategic focus on maximizing shareholder value [6].

Vancouver, BC, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that it has engaged Danayi Capital Corp. (“Danayi”) to provide digital marketing services for a two (2) month term commencing on February 9, 2026, in consideration of an up-front payment of USD$125,000. Danayi shall utilize digital marketing and online advertisements through www.wallstreetlogic.com. Danayi does not currently own any interest, directly or indirectly, ...

Core Viewpoint - Crown Point Energy Inc. has successfully issued US$30 million in Series IX secured fixed-rate notes, which will be repaid in ten equal installments starting from October 30, 2026, with a fixed interest rate of 10.75% per annum [1][4]. Group 1: Offering Details - The Series IX Notes will be repaid in ten equal installments, with the final payment due on January 30, 2029 [1]. - Interest on the Series IX Notes is set at a fixed rate of 10.75% per annum, payable quarterly [1]. - The notes are secured by a pledge on crude oil sales collections from specific concessions: El Tordillo, Puesto Quiroga, and La Tapera [1]. Group 2: Use of Proceeds - The net proceeds from the Offering will be allocated for general corporate purposes and investments in asset development in Argentina [2]. Group 3: Outstanding Notes - Following the Offering, Crown Point has several notes outstanding, including US$1,780,058 of Series V Notes, US$22 million of Series VI Notes, US$25 million of Series VII Notes, and the newly issued US$30 million of Series IX Notes [4]. Group 4: Company Overview - Crown Point is an international oil and gas exploration and development company based in Buenos Aires, Argentina, and incorporated in Alberta, Canada [5]. - The company focuses its exploration and development activities in four producing basins in Argentina: Golfo San Jorge, Austral, Neuquén, and Cuyano [5].

VANCOUVER, British Columbia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Plaid Technologies Inc. (CSE: STIF) (OTC: STIFF) (FRA: 5QX0) (“Plaid” or the “Company”) today announces the shipment of an initial quantity of its proprietary graphene material to Petro Flow LLC in advance of the first planned field tests of graphene-enhanced wellbore cement for plugging and abandonment (“P&A”) applications. The initial test wells are expected to be conducted during the second quarter of 2026 in the continental United States. Th ...

DENVER, Jan. 30, 2026 (GLOBE NEWSWIRE) -- National Bank Holdings Corporation (NYSE: NBHC, “NBHC” or the “Company”), the holding company for NBH Bank, announced today that it has granted inducement awards to 4 new employees. Each inducement award was committed to the employee in their employment agreement or offer letter, as applicable, with NBHC and/or NBH Bank and was granted as an inducement material to the employee’s commencement of employment in connection with NBHC’s acquisition of Vista Bancshares, In ...

Core Viewpoint - Enzon Pharmaceuticals has initiated an exchange offer for its Series C Non-Convertible Redeemable Preferred Stock in connection with its merger with Viskase Companies, Inc. [1] Offer Details - Enzon is offering holders of Series C Preferred Stock the opportunity to exchange their shares for common stock, with the exchange ratio based on the liquidation preference divided by $7.83, post Reverse Stock Split [2] - The Offer is fully detailed in the Prospectus/Consent Solicitation/Offer to Exchange filed with the SEC on January 28, 2026 [3] Key Dates and Information - The exchange offer commenced on January 30, 2026, and will expire at 11:59 p.m. Eastern Time on February 27, 2026, unless extended [7] - Holders can withdraw their tendered shares at any time before the deadline [7] Company Background - Enzon Pharmaceuticals, Inc. operates as a public company acquisition vehicle, aiming to become an acquisition platform [5] Additional Information - HKL & Co., LLC is the Information Agent for the Offer, while Continental Stock Transfer & Trust Company serves as the Exchange Agent [4] - Investors can access the documents filed with the SEC through the SEC's website or by contacting HKL & Co., LLC [8]

Core Viewpoint - EQV Ventures Acquisition Corp. and Presidio Investment Holdings LLC are moving forward with their business combination, with the registration statement declared effective by the SEC, and an extraordinary general meeting scheduled for February 27, 2026, to approve the merger [1][3][13]. Company Overview - EQV Ventures Acquisition Corp. is a special purpose acquisition company (SPAC) focused on merging with businesses, specifically in the oil and gas sector [8]. - Presidio Investment Holdings LLC operates in the oil and gas industry, concentrating on optimizing mature, producing oil and natural gas assets in the United States [1][7]. Business Combination Details - The extraordinary general meeting for shareholders to vote on the business combination is set for February 27, 2026, at 8:00 a.m. Central Time, to be held virtually [3]. - If approved, the combined entity will trade on the New York Stock Exchange under the ticker symbol "FTW" shortly after the meeting [3]. Financial Insights - Presidio has reported a backlog of potential acquisition targets amounting to $15 billion, which aligns with its investment criteria aimed at driving dividend growth [4]. - The company aims to return capital to shareholders at an attractive rate while executing its growth strategy [5]. Shareholder Engagement - EQV is urging all shareholders to complete and return their proxy cards to ensure their votes are counted in the upcoming extraordinary general meeting [5]. - Shareholders who do not receive the Proxy Statement/Prospectus are advised to confirm their status with their brokers or contact EQV's proxy solicitor for assistance [6].

Core Viewpoint - Elcora Advanced Materials Corp. has successfully closed a second tranche of its private placement, raising a total of approximately $2,250,000 through the issuance of 18,749,999 units at a price of $0.12 per unit [1][2]. Group 1: Private Placement Details - The second tranche involved the issuance of 10,591,666 units, generating gross proceeds of approximately $1,271,000 [1]. - The first tranche consisted of 8,158,333 units, raising approximately $979,000 [2]. - The total offering allows for the issuance of up to 25,000,000 units at $0.12 per unit, aiming for total gross proceeds of up to $3,000,000 [3]. Group 2: Insider Participation - A director of the company participated in the offering, acquiring a total of 1,183,334 units in the first tranche and 816,667 units in the second tranche, amounting to approximately $240,000 [4]. - This insider participation is classified as a "related party transaction" but is exempt from formal valuation and minority shareholder approval requirements [4]. Group 3: Use of Proceeds and Regulatory Compliance - The net proceeds from the offering will be utilized for general working capital purposes [5]. - All securities issued will be subject to a statutory hold period of four months plus a day from issuance, in accordance with applicable securities laws [5]. - The closing of the offering is contingent upon receiving all necessary regulatory approvals and final acceptance by the TSX Venture Exchange [5]. Group 4: Company Overview - Elcora Advanced Materials Corp. was founded in 2011 and is structured to be a vertically integrated battery material company [6]. - The company specializes in processing, refining, and producing battery-related minerals and metals, with a focus on developing cost-effective purification processes for high-quality battery materials [6].